Where is the Place of Surgery for N2 Disease?

被引：0
|
作者：
Van Schil, Paul [1 ]
Faivre-Finn, Corinne [2 ,3 ]
机构：
[1] Antwerp Univ Hosp, Thorac & Vasc Surg, Antwerp, Belgium
[2] Univ Manchester, Radiotherapy Res Related, Manchester, Lancs, England
[3] Christie NHS Fdn Trust, Manchester, Lancs, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
induction therapy; Chemo-radiotherapy; Surgery; stage IIIA-N2 disease; CELL LUNG-CANCER; SALVAGE SURGERY; RADIOTHERAPY; CHEMOTHERAPY; GUIDELINES;
D O I：
10.1016/j.jtho.2016.11.138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MTE05.01
引用
收藏
页码：S152 / S154
页数：3
相关论文
共 50 条
  • [21] Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation
    Chai, Yanfei
    Ma, Yuchao
    Feng, Wei
    Lu, Hongwei
    Jin, Longyu
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [22] Upfront surgery for N2 NSCLC: a large retrospective multicenter cohort study
    Campisi, Alessio
    Catelli, Chiara
    Gabryel, Piotr
    Giovannetti, Riccardo
    Dell'Amore, Andrea
    Kasprzyk, Mariusz
    Piwkowski, Cezary
    Infante, Maurizio
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2023, 71 (12) : 715 - 722
  • [23] Issues in Management of N2 disease in NSCLC
    Kumar, Tarun
    Jiwnani, Sabita
    Karimundackal, George
    Pramesh, C. S.
    ANNALS OF THORACIC SURGERY, 2015, 99 (02) : 744 - 745
  • [24] Results of N1 and N2 surgery in non-small cell lung cancer
    Pfannschmidt, J.
    Kollmeier, J.
    CHIRURG, 2019, 90 (12): : 974 - 981
  • [25] Is there a place for surgical management in stage IIIA N2 non-small cell lung cancer?
    Pages, P. -B.
    Pforr, A.
    Delpy, J. -P.
    Abou Hanna, H.
    Bernard, A.
    REVUE DES MALADIES RESPIRATOIRES, 2015, 32 (05) : 485 - 492
  • [26] Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy?
    Lococo, Filippo
    Chiappetta, Marco
    Sassorossi, Corolina
    Nachira, Dania
    Evangelista, Jessica
    Ciavarella, Leonardo Petracca
    Congedo, Maria Teresa
    Porziella, Venanzio
    Boldrini, Luca
    Larici, Annarila
    Bria, Emilio
    Margaritora, Stefano
    REVIEWS ON RECENT CLINICAL TRIALS, 2022, 17 (02) : 103 - 108
  • [27] Splitting hairs or not: importance of N2 subclassification after neoadjuvant treatment and surgery COMMENT
    Chan, Joyce W. Y.
    Lau, Rainbow W. H.
    Ng, Calvin S. H.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 61 (02) : 277 - 278
  • [28] Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancer
    De Craene, Sofie
    Surmont, Veerle
    van Meerbeeck, Jan P.
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (02) : 102 - 111
  • [29] HECATE: THE MANY FACES OF N2 DISEASE Reply
    Lin, Jules
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 152 (05) : 1464 - 1465
  • [30] Surgical Outcomes after Initial Surgery for Clinical Single-station N2 Non-small-cell Lung Cancer
    Hishida, Tomoyuki
    Yoshida, Junji
    Ohe, Yuichiro
    Aokage, Keiju
    Ishii, Genichiro
    Nagai, Kanji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (01) : 85 - 92
12345